Physician profile
Charles L Branch
NPI 1821078403
$1,634,130.40
in general payments reported to CMS, 2019-2025
8 companies · $1.1M in 2025
The $1.1M reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,640 · 2020: $15K · 2021: $12K · 2022: $21K · 2023: $18K · 2024: $500K · 2025: $1.1M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.5M · Consulting Fee: $35K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Travel and Lodging: $4,451 · Food and Beverage: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,522,775.00 |
| Consulting Fee | $35,307.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,165.00 |
| Travel and Lodging | $4,451.19 |
| Food and Beverage | $944.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,561,077.09 | 2021-2025 | Catalyft Pl Expandable Interbody System, Space-D System 5.5/6.0 Voyager Instrument Set, Aquamantys(Tm) |
| Olympus America INC. | $33,545.71 | 2021-2023 | Orbeye Surgical Microscope, Olympus |
| Alphatec Spine, INC | $20,888.64 | 2024-2025 | Other - Miscellaneous |
| Medtronic USA, INC. | $17,376.45 | 2019-2020 | |
| Olympus Corporation of The Americas | $1,058.56 | 2021-2023 | Olympus |
| Bone Support INC. | $128.89 | 2019 | |
| Medical Device Business Services, INC. | $44.27 | 2022 | |
| Stryker Corporation | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Branch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.